Establishment Labs Holdings (ESTA) Income towards Parent Company (2017 - 2026)
Establishment Labs Holdings (ESTA) posted Income towards Parent Company of -$11.7 million for Q2 2026, up 12.21% on a QoQ basis from -$13.4 million in Q1 2026, and up 29.2% year-over-year from -$9.1 million in Q2 2025.
Analysis
Establishment Labs Holdings (ESTA) Income towards Parent Company (2017 - 2026) Analysis & Trends
Establishment Labs Holdings has reported Income towards Parent Company for 10 years, with the latest figure at -$11.7 million in Q2 2026.
- On a quarterly basis, Income towards Parent Company rose 29.2% year-over-year to -$11.7 million in Q2 2026; TTM through Jun 2026 was -$38.9 million, a 56.06% increase from a year earlier, with the FY2025 full-year figure at -$51.1 million, up 39.64% from the prior year.
- Income towards Parent Company was -$11.7 million for Q2 2026 at Establishment Labs Holdings, up from -$13.4 million in the prior quarter.
- The five-year high for Income towards Parent Company was -$2.6 million in Q4 2025, with the low at -$37.1 million in Q2 2022.
- Average Income towards Parent Company over 5 years is -$17.5 million, with a median of -$16.6 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Income towards Parent Company plunged 597.22% in 2022, then surged 92.43% in 2025.
- Over 5 years, Income towards Parent Company stood at -$13.6 million in 2022, then sank by 51.47% to -$20.5 million in 2023, then slumped by 68.1% to -$34.5 million in 2024, then soared by 92.43% to -$2.6 million in 2025, then slumped by 349.25% to -$11.7 million in 2026.
- The last three Income towards Parent Company figures came in at -$11.7 million (Q2 2026), -$13.4 million (Q1 2026), and -$2.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 178.50 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.21 Bn | 118.99 Bn | 1.96 Bn |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.39 Bn | 65.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.69 Bn | 45.43 Bn | 1.35 Bn |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 21.15 Bn | 20.67 Bn | 684.20 Mn |
| 10 | Establishment Labs Holdings | 2.25 Bn | 2.18 Bn | 47.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.75 Mn |
| Mar 31, 2026 | -13.38 Mn |
| Dec 31, 2025 | -2.62 Mn |
| Sep 30, 2025 | -11.15 Mn |
| Jun 30, 2025 | -16.59 Mn |
| Mar 31, 2025 | -20.71 Mn |
| Dec 31, 2024 | -34.53 Mn |
| Sep 30, 2024 | -16.68 Mn |
| Jun 30, 2024 | -17.18 Mn |
| Mar 31, 2024 | -16.20 Mn |
| Dec 31, 2023 | -20.54 Mn |
| Sep 30, 2023 | -29.27 Mn |
| Jun 30, 2023 | -16.75 Mn |
| Mar 31, 2023 | -11.94 Mn |
| Dec 31, 2022 | -13.56 Mn |
| Sep 30, 2022 | -18.61 Mn |
| Jun 30, 2022 | -37.11 Mn |
| Mar 31, 2022 | -5.93 Mn |
| Dec 31, 2021 | -14.19 Mn |
| Sep 30, 2021 | -14.68 Mn |